Health Condition 1: null- Characterize HF patients at hospitalization and assess in-hospital and post-discharge eventsâ?? incidence (i.e., cardiac and non-cardiac primary cause of re-hospitalization, mortality)
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Novartis AG
Eligibility
Inclusion criteria
Inclusion criteria: Patients eligible for inclusion in this study have to fulfill all of the following criteria: 1)Patients 18 year old, or older for those countries where the adult age is above 18 year of age, hospitalized at the registry sites with primary diagnosis of acute heart failure. Diagnoses will be made by the treating physicians according to local practices and their clinical judgment (i.e., History/examination; Chest X-ray; ECG, Echocardiogram, BNP or NT-proBNP).
Exclusion criteria
Exclusion criteria: Patients eligible for inclusion in this study have to fulfill all of the following criteria: 1. Patients 18 year old, or older for those countries where the adult age is above 18 year of age, hospitalized at the registry sites with primary diagnosis of acute heart failure. Diagnoses will be made by the treating physicians according to local practices and their clinical judgment (i.e., History/examination; Chest X-ray; ECG, Echocardiogram, BNP or NT-proBNP).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To identify best practice in the HF treatment, as well as extent of healthcare resources use.Timepoint: every 6 month till 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| to collect data on health-related quality of life as well as economic and caregiver burdenTimepoint: every 6 month till 3 years | — |
Countries
Argentina, Austria, Chile, China, Colombia, Germany, Greece, India, Malaysia, Norway, Sweden, Switzerland, United Arab Emirates, United Kingdom
Contacts
Public ContactMurugananthan K
Novartis Healthcare Private Limited
Outcome results
None listed